Cancer is one of the most prevalent diseases worldwide,which causes significant morbidity and mortality.Designing and developing a potential anti-cancer drug is an active field of research worldwide.Microorganisms hav...Cancer is one of the most prevalent diseases worldwide,which causes significant morbidity and mortality.Designing and developing a potential anti-cancer drug is an active field of research worldwide.Microorganisms have been considered a potential source of anti-cancer drugs.One such microbe-derived compound is surfactin,which shows potential anti-cancer activities.In this study,we evaluated the binding potential of surfactin with several cancer cell ligands via an in-silico approach.Hence,molecular docking studies were performed to test the binding potential of surfactin against four targets.The analyses revealed that surfactin from Bacillus sp.can bind with the targeted ligands(coenzyme A,D-leucine,glycerol,and(R)-3-hydroxytetradecanal)with significant affinity.Surfactin showed the highest binding affinity(-7.7 kcal mol-1)to coenzyme A among the targeted ligands.These results may be useful for developing anti-cancer drugs.Nevertheless,further experimental studies are needed to investigate the ligand binding capacity and anti-cancer potential of such surfactin-like molecules.展开更多
Type 2 diabetes mellitus(T2DM)is associated with liver dysfunction and intestinal dysbiosis.Bioactive peptides(BAPs)have been reported to ameliorate T2DM by preventing oxidative damage to the liver.Bacillus amylolique...Type 2 diabetes mellitus(T2DM)is associated with liver dysfunction and intestinal dysbiosis.Bioactive peptides(BAPs)have been reported to ameliorate T2DM by preventing oxidative damage to the liver.Bacillus amyloliquefaciens fmb50 produces the lipopeptide surfactin with a wide range of biological activities.The effects of surfactin on T2DM,on the other hand,have not been studied.In the present study,80 mg/kg body weight surfactin supplementation lowered fasting blood glucose(FBG)levels by 21.05%and insulin resistance(IR)by 18.18%compared with those in the T2DM group,reduced inflammation,and increased antioxidant activity in mice with T2DM induced by a high-fat diet(HFD)and streptozotocin(STZ).According to further research,surfactin administration reduced Firmicutes-to-Bacteroidetes ratios while increasing Bifi dobacterium abundance by 20 times and the level of the tight junction protein Occludin by 18.38%and ZO-1 by 66.60%.Furthermore,surfactin also improved hepatic glucose metabolism by activating the adenosine monophosphate-activated protein kinase(AMPK)signalling pathway,increasing glycogen synthesis and glucose transporter 2(GLUT2)protein expression while reducing glucose-6-phosphatase(G6Pase)protein expression.In addition,the increased Bifi dobacterium abundance indirectly reduced the liver burden of the metabolic products indole,cresol and amine produced by saprophytic bacteria.All of these findings revealed that surfactin not only ameliorated HFD/STZ-induced gut dysbiosis and preserved intestinal barrier integrity but also enhanced hepatic glucose metabolism and detoxifi cation function in T2DM mice.The gut microbiota appeared to be important in controlling glucose metabolism,IR,fat accumulation,inflammation and antioxidation,according to Spearman’s correlation coeffi cients.All data indicated that surfactin alleviated hyperglycaemia in mice with T2DM induced by HFD/STZ.展开更多
采用白金板法对Surfactin的表面活性进行研究,并用浊度法和离心法对其乳化性进行研究。结果表明：Surfactin的临界胶束浓度为9.03×10-5 mol/L,可将水的表面张力由73.98 m N/m降至最低27.48 m N/m。在浓度为1×10-3~1.2×10...采用白金板法对Surfactin的表面活性进行研究,并用浊度法和离心法对其乳化性进行研究。结果表明：Surfactin的临界胶束浓度为9.03×10-5 mol/L,可将水的表面张力由73.98 m N/m降至最低27.48 m N/m。在浓度为1×10-3~1.2×10-2 mol/L的NaCl溶液中,Surfactin溶液的表面张力随盐浓度升高逐渐降低并最终稳定在34 m N/m;Surfactin在121℃处理20 min后,其表面张力仍能保持在37.10 m N/m;在pH值为2~12范围内,其表面活性稳定并良好;表明Surfactin具有较强的NaCl浓度、温度、pH值的耐受性。浊度法测得Surfactin亲水亲油平衡（hydrophile lipophilic balance,HLB）值为14,对所需HLB值为12~16的油相乳化性能良好。展开更多
为了明确surfactin产量不同的芽孢杆菌对黄瓜枯萎病的控制作用,本研究采用N+注入诱变共获得1250株芽孢杆菌B006的突变株,通过对黄单孢杆菌的抑菌试验筛选并获得3株产surfactin突变株B841、B73和B1020。对各突变株NB发酵液的HPLC ESI MS...为了明确surfactin产量不同的芽孢杆菌对黄瓜枯萎病的控制作用,本研究采用N+注入诱变共获得1250株芽孢杆菌B006的突变株,通过对黄单孢杆菌的抑菌试验筛选并获得3株产surfactin突变株B841、B73和B1020。对各突变株NB发酵液的HPLC ESI MS分析表明:突变株B841和B73的surfactin含量比野生菌株B006分别升高了15.9%和14.8%,而突变株B1020的surfactin含量比野生菌株降低了85.2%;各突变株fengycin产量未发生改变。对surfactin各组分的质谱图解析,发现突变株B841和B1020的surfactin组分发生变化,突变株B841的surfactin组分中无m/z为995的同系物,而突变株B1020的MS图谱中只发现了m/z为1037和1051的surfactin同系物;对突变株的生物学特性测定表明:突变株B73和B1020的菌落形态发生改变,生长周期缩短;3个突变株比野生菌株产芽孢能力下降,突变株B1020在含有玉米粉和豆饼粉的培养基上不产生芽孢。对各菌株添加到育苗基质中(浓度为106cfu·g 1)后,防治黄瓜枯萎病的效果测定表明:2周时,突变株B1020防效接近于野生菌株B006,达70%以上;但3周时,防效下降到36.2%;突变株B841防效始终低于野生菌株B006,只有29.1%。本研究发现芽孢杆菌B006及其突变株在NA培养液中的surfactin产量的高低与其在育苗基质中的防病效果无直接的相关性,对其在自然土中的防病效果值得进一步研究。展开更多
文摘Cancer is one of the most prevalent diseases worldwide,which causes significant morbidity and mortality.Designing and developing a potential anti-cancer drug is an active field of research worldwide.Microorganisms have been considered a potential source of anti-cancer drugs.One such microbe-derived compound is surfactin,which shows potential anti-cancer activities.In this study,we evaluated the binding potential of surfactin with several cancer cell ligands via an in-silico approach.Hence,molecular docking studies were performed to test the binding potential of surfactin against four targets.The analyses revealed that surfactin from Bacillus sp.can bind with the targeted ligands(coenzyme A,D-leucine,glycerol,and(R)-3-hydroxytetradecanal)with significant affinity.Surfactin showed the highest binding affinity(-7.7 kcal mol-1)to coenzyme A among the targeted ligands.These results may be useful for developing anti-cancer drugs.Nevertheless,further experimental studies are needed to investigate the ligand binding capacity and anti-cancer potential of such surfactin-like molecules.
基金supported by the National Natural Science Foundation of China(32072182)。
文摘Type 2 diabetes mellitus(T2DM)is associated with liver dysfunction and intestinal dysbiosis.Bioactive peptides(BAPs)have been reported to ameliorate T2DM by preventing oxidative damage to the liver.Bacillus amyloliquefaciens fmb50 produces the lipopeptide surfactin with a wide range of biological activities.The effects of surfactin on T2DM,on the other hand,have not been studied.In the present study,80 mg/kg body weight surfactin supplementation lowered fasting blood glucose(FBG)levels by 21.05%and insulin resistance(IR)by 18.18%compared with those in the T2DM group,reduced inflammation,and increased antioxidant activity in mice with T2DM induced by a high-fat diet(HFD)and streptozotocin(STZ).According to further research,surfactin administration reduced Firmicutes-to-Bacteroidetes ratios while increasing Bifi dobacterium abundance by 20 times and the level of the tight junction protein Occludin by 18.38%and ZO-1 by 66.60%.Furthermore,surfactin also improved hepatic glucose metabolism by activating the adenosine monophosphate-activated protein kinase(AMPK)signalling pathway,increasing glycogen synthesis and glucose transporter 2(GLUT2)protein expression while reducing glucose-6-phosphatase(G6Pase)protein expression.In addition,the increased Bifi dobacterium abundance indirectly reduced the liver burden of the metabolic products indole,cresol and amine produced by saprophytic bacteria.All of these findings revealed that surfactin not only ameliorated HFD/STZ-induced gut dysbiosis and preserved intestinal barrier integrity but also enhanced hepatic glucose metabolism and detoxifi cation function in T2DM mice.The gut microbiota appeared to be important in controlling glucose metabolism,IR,fat accumulation,inflammation and antioxidation,according to Spearman’s correlation coeffi cients.All data indicated that surfactin alleviated hyperglycaemia in mice with T2DM induced by HFD/STZ.
文摘采用白金板法对Surfactin的表面活性进行研究,并用浊度法和离心法对其乳化性进行研究。结果表明：Surfactin的临界胶束浓度为9.03×10-5 mol/L,可将水的表面张力由73.98 m N/m降至最低27.48 m N/m。在浓度为1×10-3~1.2×10-2 mol/L的NaCl溶液中,Surfactin溶液的表面张力随盐浓度升高逐渐降低并最终稳定在34 m N/m;Surfactin在121℃处理20 min后,其表面张力仍能保持在37.10 m N/m;在pH值为2~12范围内,其表面活性稳定并良好;表明Surfactin具有较强的NaCl浓度、温度、pH值的耐受性。浊度法测得Surfactin亲水亲油平衡（hydrophile lipophilic balance,HLB）值为14,对所需HLB值为12~16的油相乳化性能良好。
文摘为了明确surfactin产量不同的芽孢杆菌对黄瓜枯萎病的控制作用,本研究采用N+注入诱变共获得1250株芽孢杆菌B006的突变株,通过对黄单孢杆菌的抑菌试验筛选并获得3株产surfactin突变株B841、B73和B1020。对各突变株NB发酵液的HPLC ESI MS分析表明:突变株B841和B73的surfactin含量比野生菌株B006分别升高了15.9%和14.8%,而突变株B1020的surfactin含量比野生菌株降低了85.2%;各突变株fengycin产量未发生改变。对surfactin各组分的质谱图解析,发现突变株B841和B1020的surfactin组分发生变化,突变株B841的surfactin组分中无m/z为995的同系物,而突变株B1020的MS图谱中只发现了m/z为1037和1051的surfactin同系物;对突变株的生物学特性测定表明:突变株B73和B1020的菌落形态发生改变,生长周期缩短;3个突变株比野生菌株产芽孢能力下降,突变株B1020在含有玉米粉和豆饼粉的培养基上不产生芽孢。对各菌株添加到育苗基质中(浓度为106cfu·g 1)后,防治黄瓜枯萎病的效果测定表明:2周时,突变株B1020防效接近于野生菌株B006,达70%以上;但3周时,防效下降到36.2%;突变株B841防效始终低于野生菌株B006,只有29.1%。本研究发现芽孢杆菌B006及其突变株在NA培养液中的surfactin产量的高低与其在育苗基质中的防病效果无直接的相关性,对其在自然土中的防病效果值得进一步研究。
